<DOC>
	<DOCNO>NCT00495729</DOCNO>
	<brief_summary>Subjects screen within 28 day , Simvastatin dose single SB-649868 dose 10 7 day prior repeat dose respectively , 15 day SB-649868 repeat dose safety cognition function test .</brief_summary>
	<brief_title>15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects .</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Healthy adult male subject age 18 65 year age inclusive . Body weight =50 kg BMI within range 18.529.9 kg/m2 inclusive . Healthy judge responsible physician . No clinically significant abnormality identify medical laboratory evaluation 12lead ECG . A subject clinical abnormality laboratory parameter outside reference range age group may include Investigator Medical Monitor consider find introduce additional risk factor interfere study procedure . Subjects blood pressure measurement within normal range healthy volunteer . The subject positive prestudy urine drug/ alcohol urine screen . A positive prestudy Hepatitis B surface antigen , Hepatitis C antibody , HIV 1/2 result screen visit . Abuse alcohol define average weekly intake great 21 unit average daily intake great 3 unit . Subject complains sleep disturbance and/ receive treatment sleep disorder .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>SB-649868 ,</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>Repeated dose ,</keyword>
</DOC>